We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+15.06%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$7.11B
AUM Growth
-$565M
Cap. Flow
-$1.43B
Cap. Flow %
-20.08%
Top 10 Hldgs %
20.64%
Holding
332
New
78
Increased
81
Reduced
110
Closed
62

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$71.9M
2
SIVB
SVB Financial Group
SIVB
+$50.7M
3
ROK icon
Rockwell Automation
ROK
+$48.9M
4
PE
PARSLEY ENERGY INC
PE
+$48.2M
5
COST icon
Costco
COST
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 21.81%
2 Consumer Discretionary 17.27%
3 Healthcare 16.33%
4 Industrials 13.31%
5 Financials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MX icon
251
Magnachip Semiconductor
MX
$145M
$900K 0.01%
+94,263
New +$742K
AIMT
252
DELISTED
Aimmune Therapeutics
AIMT
$897K 0.01%
+41,259
New +$846K
BHC icon
253
Bausch Health
BHC
$2.34B
$830K 0.01%
75,252
+14,880
+25% +$205K
CFMS
254
DELISTED
Conformis, Inc. Common Stock
CFMS
$792K 0.01%
+6,066
New +$1.03M
RCKT icon
255
Rocket Pharmaceuticals
RCKT
$394M
$770K 0.01%
96,307
+42,315
+78% +$285K
NEOS
256
DELISTED
Neos Therapeutics, Inc
NEOS
$767K 0.01%
106,520
+64,216
+152% +$398K
EGHT icon
257
CALL
8x8 Inc
EGHT
$332M
$721K 0.01%
+47,300
New +$717K
IRTC icon
258
iRhythm Holdings
IRTC
$4.2B
$714K 0.01%
+18,998
New +$654K
OCLR
259
DELISTED
Oclaro Inc.
OCLR
$712K 0.01%
72,488
-26,647
-27% -$250K
TXMD icon
260
CALL
TherapeuticsMD
TXMD
$24M
$702K 0.01%
+1,950
New +$603K
OCLR
261
CALL
DELISTED
Oclaro Inc.
OCLR
$686K 0.01%
+69,900
New +$656K
PBYI icon
262
Puma Biotechnology
PBYI
$454M
$667K 0.01%
+17,921
New +$654K
NSTG
263
DELISTED
NanoString Technologies, Inc.
NSTG
$620K 0.01%
31,181
+6,649
+27% +$126K
IPXL
264
DELISTED
Impax Laboratories, Inc.
IPXL
$532K 0.01%
+42,047
New +$508K
HQY icon
265
HealthEquity
HQY
$8.75B
$461K 0.01%
+10,854
New +$480K
AVDL
266
DELISTED
Avadel Pharmaceuticals
AVDL
$424K 0.01%
43,822
-5,493
-11% -$54.9K
ADBE icon
267
Adobe
ADBE
$105B
$305K ﹤0.01%
+2,344
New +$275K
P
268
DELISTED
Pandora Media Inc
P
$301K ﹤0.01%
25,490
-3,631
-12% -$45.6K
CCI icon
269
Crown Castle
CCI
$32.2B
$300K ﹤0.01%
+3,174
New +$284K
VRNT
270
DELISTED
Verint Systems
VRNT
$295K ﹤0.01%
+13,331
New +$260K
ALGN icon
271
Align Technology
ALGN
$12.3B
-471,218
Closed -$45.3M
AMED
272
DELISTED
Amedisys
AMED
-17,294
Closed -$737K
AMGN icon
273
PUT
Amgen
AMGN
$222B
-35,000
Closed -$5.12M
AON icon
274
Aon
AON
$76B
-97,952
Closed -$10.9M
ATRC icon
275
AtriCure
ATRC
$2.11B
-104,179
Closed -$2.04M

Similar funds

Columbus Circle Investors's Q1 2017 Portfolio in Review

As of Q1 2017, Columbus Circle Investors held 332 positions worth $7.11B, down 7.4% from $7.67B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Columbus Circle Investors withdrew a net $1.43B in Q1 2017, closing 62 positions and reducing 110 holdings. Its most notable exit was Fidelity National Information Services, an estimated $84M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Columbus Circle Investors opened a new position in SVB Financial Group worth $51.8M.

  • Columbus Circle Investors's largest Q1 2017 buy was SVB Financial Group: 278,577 shares worth $51.8M.
  • Columbus Circle Investors added most to Merck in Q1 2017, an estimated $71.9M increase.
  • Columbus Circle Investors's biggest Q1 2017 reduction was Pioneer Natural Resource Co., cutting an estimated $100M.
  • Columbus Circle Investors fully exited Fidelity National Information Services in Q1 2017, selling an estimated $84M.
  • Columbus Circle Investors's ten largest holdings make up 21% of its $7.11B portfolio in Q1 2017.
  • Columbus Circle Investors opened 78 new positions and closed 62 in Q1 2017.
  • Columbus Circle Investors's portfolio value fell 7.4% quarter-over-quarter to $7.11B.

Based on Columbus Circle Investors's 13F filing for Q1 2017, filed 20 Apr 2017.